|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 48/00 | |||
| C07K 16/18 |
| (11) | Patento numeris | 2978451 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14722916.5 |
| Europos patento paraiškos padavimo data | 2014-03-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-02-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/032209 |
| Data | 2014-03-28 |
| (87) | Numeris | WO 2014/160958 |
| Data | 2014-10-02 |
| (30) | Numeris | Data | Šalis |
| 201361806687 P | 2013-03-29 | US |
| (72) |
HUNTER, Jeffrey, W., US
TAMBURINI, Paul, P., US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | COMPOSITIONS AND METHODS FOR INCREASING THE SERUM HALF-LIFE OF A THERAPEUTIC AGENT TARGETING COMPLEMENT C5 |
| COMPOSITIONS AND METHODS FOR INCREASING THE SERUM HALF-LIFE OF A THERAPEUTIC AGENT TARGETING COMPLEMENT C5 |